To include your compound in the COVID-19 Resource Center, submit it here.
Eidos Therapeutics Inc. (Palo Alto, Calif.) and Avrobio Inc. (Cambridge, Mass.) proposed NASDAQ IPOs on Friday.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury